Bespoke market research - IVD and healthcare markets

1. Bespoke Research Services
PARIOFORMA LTD
55 Princes Gate
Exhibition Road
London SW7 2PN
United Kingdom
Tel: +44 (0) 20 7225 3538
www.parioforma.com
PARIOFORMA

2. PARIOFORMA
 Parioforma have been providing bespoke research services to the Healthcare and Life Sciences
industries for over 20 years.
 We can help you better understand your customer needs, evaluate the competitive landscape or assess
the market opportunity for a new product or service.
 Research can be global, regional or country-specific and all projects are tailored to individual customer
needs – studies typically include aspects of the following:
2
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com
• Review of the IVD market and/or a
specific market segment
• Market analysis:
 Value
 Growth rates
 Sector shares
 Growth regulators
 Business trends
 Technology trends
• Customer analysis:
 Voice of the customer
 Customer segmentation
• Competitive environment:
 Corporate profiles
 Market shares
 New entrants
• Partner and/or investor
identification

3. PARIOFORMA
 Diagnostic tests were performed close to 4 billion times in 2013 in the United States:
3
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com
Drivers for the US IVD Market
• Technological advances and automation have made
tests easier to use and more accurate, and have led
to more precise and more timely results.
• Advances have led to point-of-care tests that
facilitate more rapid decision-making by medical
practitioners.
• Number of diagnostic tests required being driven by
the aging and the growth of the population.
• Increased use of diagnostic tests as quality indicators.
• Increased consumer awareness of, and demand for,
tests.
• Extension of health insurance coverage by the
Affordable Care Act of 2010.
Restraints for the US IVD Market
• Challenges exist in gaining FDA clearance - the level
of evidence required to demonstrate safety and
effectiveness, as well as clinical utility continues to
grow.
• Difficulties in securing insurance coverage - insurers
insist on direct evidence of clinical utility and the
impact of a specific test on patient outcomes.
• Reimbursement rates paid for some tests do not
cover the costs of providing the service.

4. PARIOFORMA
 The US Infectious Disease Rapid Testing Market – porter’s analysis:
4
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com
Threat of New Entrants
+ High barriers to entry
- Medium customer loyalty
- High profitability attracts new entrants
Low
Threat of Substitutes
+ Medium high switching costs (CLIA moderate
or above)
- Transition to innovative rapid molecular tests
Medium - High
Competitive Rivalry
- High for technical, marketing and sales
- Consolidation has concentrated the market
toward the larger companies
High
Bargaining Power of
Buyers
- Many RDT test
platforms with similar
performance giving
customers a lot to
choose from
- Price sensitivity
High
Bargaining Power of
Suppliers
- Reliance upon third-
party vendors/
distributors
- Consolidation in the lab
marketplace
+ Increasing POLs and
alternative testing sites
Medium

5. PARIOFORMA
 User perceptions of US rapid test reader devices:
5
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com
Price Dual Power
– mains &
battery
Portability Connectivity Test Menu CLIA Status Walk- Away
Potential
Short-term    --    
Mid to long-
term
 --     
Key:  Very Important;  Important; -- Neutral;   Not important;

6. PARIOFORMA
 Drivers & restraints in India’s IVD market:
6
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com

7. PARIOFORMA
 Customer landscape in India:
7
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com

8. PARIOFORMA
 Influencers on the patient choice of SMBG meter in Turkey:
8
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com
Interview respondents were asked to
rate the extent of influence in the
patient choice of meter on a scale of 1-7
[where 1 = low; 7 = high]
The pharmacist has the greatest
influence on the buying decision –
patients place a lot of trust in this
relationship.

9. PARIOFORMA
LONDON OFFICE ASSOCIATE OFFICES
Charles Rowlands
Senior Partner
55 Prince’s Gate
Exhibition Road
London SW7 2PN
United Kingdom
Tel: +44 (0) 7803 907577
www.parioforma.com
USA
Intrix Corp, Darien
Connecticut
Eastern
Europe
IMRP, Moscow
Brazil
Intrix Corp, São
Paulo
Japan TRN, Tokyo
Parioforma Ltd. Is an independent business consultancy headquartered in London, UK.
Key benefits of working with Parioforma:
 Bespoke studies – tailored to client needs and
timelines.
 Affordable research prices – makes budgets go
further.
 High quality research – experienced science-based
team, all with post-graduate science and/ or MBA
qualifications and with 10-25+ years experience in Life
Science and High Technology industries.
 Unique problem solving approach – the team is
highly specialised, but diverse in experience and
background, enabling analysis of problems from
different perspectives.
 Strategic Pointers – helps clients better understand
the research and implications for their business.
 Practical implementable solutions – not just
“over-clever analysis.”
Our knowledge is extensive and experience
broad – please visit our website for a full
listing of all our services.
Please don't hesitate to contact us for an informal
discussion on your market research needs – either by
telephone on +44 (0) 207 225 3538 or by email at:
charles.rowlands@parioforma.com
9
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com